BIOMARIN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 4BMRN for the last quarter is 661.60 M EUR, and it's 9.83% higher compared to the previous quarter. The net income of Q2 24 is 100.06 M EUR.